Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir

about

Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir

Item

http://www.wikidata.org/entity/Q58602166

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@en

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@nl

type

Item

label

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@en

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@nl

prefLabel

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@en

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@nl

P1476

Recovery of natural killer cel ...... ith sofosbuvir plus ledipasvir

@en

P2093

Bi-Fen Luo

http://www.w3.org/2001/XMLSchema#string

Bo Feng

http://www.w3.org/2001/XMLSchema#string

Dan-Li Ma

http://www.w3.org/2001/XMLSchema#string

Han-Ji Jiang

http://www.w3.org/2001/XMLSchema#string

Lai Wei

http://www.w3.org/2001/XMLSchema#string

Qian Jin

http://www.w3.org/2001/XMLSchema#string

Xiao-Xiao Wang

http://www.w3.org/2001/XMLSchema#string

Xu Cong

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment responses in Asians and Caucasians with chronic hepatitis C infection

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Hepatitis C Virus and Human Cytomegalovirus-Natural Killer Cell Subsets in Persistent Viral Infections.

Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents.

On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

Innate and adaptive lymphoid cells in the human liver.

P304

4554-4564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V24.I40.4554

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386105

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

P932

6209576

http://www.w3.org/2001/XMLSchema#string